Prospects for eradication of meningococcal disease

Meningococcal meningitis and septicaemia remain a serious global health threat. This review focuses on the epidemiology of meningococcal disease following the recent implementation of effective vaccines and the potential utility of a vaccine against serogroup B meningococcus.

• Publication year

  2012

• Venue

  Archives of Disease in Childhood

• Publication date

  2012-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/archdischild-2012-302036PMID 22984187PMCID 3512348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

  2012influential reference
• Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study.

  2012cited by this paper
• 美国疾病预防控制中心（Centers for Diseases Control and Prevention，CDC）：美国流感季节到来

  2011cited by this paper
• Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease

  2011cited by this paper
• Neisseria meningitidis B vaccines

  2011cited by this paper
• Estimation of RF energy absorbed in the brain from mobile phones in the Interphone Study

  2011cited by this paper
• A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression.

  2011cited by this paper
• BROAD

  2011cited by this paper
• Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

  2010cited by this paper
• The Meningococcal Vaccine Candidate Neisserial Surface Protein A (NspA) Binds to Factor H and Enhances Meningococcal Resistance to Complement

  2010cited by this paper
• Epidemiological profile of meningococcal disease in the United States.

  2010cited by this paper
• Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis.

  2010cited by this paper
• Meningococcal carriage by age: a systematic review and meta-analysis.

  2010cited by this paper
• Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

  2010cited by this paper
• Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine.

  2010cited by this paper
• Reverse vaccinology: developing vaccines in the era of genomics.

  2010cited by this paper
• Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease.

  2010cited by this paper
• Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years.

  2009cited by this paper
• Variation of the factor H-binding protein of Neisseria meningitidis

  2009cited by this paper
• Longer-term psychiatric adjustment of children and parents after meningococcal disease

  2009cited by this paper
• Global epidemiology of meningococcal disease.

  2009cited by this paper
• Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.

  2009cited by this paper
• Infectious Diseases in the Pediatric Intensive Care Unit

  2008cited by this paper
• Factor H-Binding Protein Is Important for Meningococcal Survival in Human Whole Blood and Serum and in the Presence of the Antimicrobial Peptide LL-37

  2008cited by this paper
• Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study

  2008cited by this paper
• Conquering the meningococcus.

  2007cited by this paper
• Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.

  2007influential reference
• Immunogenicity and Safety of a Combination of Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines

  2007cited by this paper
• Interactions between Neisseria meningitidis and the complement system.

  2007cited by this paper
• A review of vaccine research and development: meningococcal disease.

  2006cited by this paper
• Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit.

  2006cited by this paper
• A universal vaccine for serogroup B meningococcus.

  2006cited by this paper
• MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain.

  2005cited by this paper
• Influence of age and carriage status on salivary IgA to Neisseria meningitidis

  2005cited by this paper
• Stability of PorA during a Meningococcal Disease Epidemic

  2005cited by this paper
• Public health strategies for preventing and controlling overweight and obesity in school and worksite settings: a report on recommendations of the Task Force on Community Preventive Services.

  2005cited by this paper
• Lack of Serum Bactericidal Activity in Preschool Children Two Years After a Single Dose of Serogroup C Meningococcal Polysaccharide-Protein Conjugate Vaccine

  2005cited by this paper
• Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2005cited by this paper
• Impact of Haemophilus influenzae Type b Conjugate Vaccine in South Africa and Argentina

  2004cited by this paper
• Protective Activity of Monoclonal Antibodies to Genome-Derived Neisserial Antigen 1870, a Neisseria meningitidis Candidate Vaccine1

  2004cited by this paper
• Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

  2003cited by this paper
• Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease.

  2003cited by this paper
• Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870

  2003cited by this paper
• Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.

  2002cited by this paper
• Neisseria lactamica Protects against Experimental Meningococcal Infection

  2002cited by this paper
• Meningococcal disease.

  2001cited by this paper
• Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.

  2000cited by this paper
• Complete genome sequence of Neisseria meningitidis serogroup B strain MC58.

  2000cited by this paper
• Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine.

  2000cited by this paper
• Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults.

  2000cited by this paper
• Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.

  1999cited by this paper
• Specificity of Bactericidal Antibody Response to Serogroup B Meningococcal Strains in Brazilian Children after Immunization with an Outer Membrane Vaccine

  1998cited by this paper
• Immune Responses against Major Outer Membrane Antigens of Neisseria meningitidis in Vaccinees and Controls Who Contracted Meningococcal Disease during the Norwegian Serogroup B Protection Trial

  1998cited by this paper
• Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  1996cited by this paper
• Meningococcal disease.

  1995cited by this paper
• Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.

  1991cited by this paper
• Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.

  1991influential reference
• Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group.

  1990cited by this paper
• Meningococcal carriage, meningococcal disease and vaccination.

  1988cited by this paper
• Meningococcal Meningitis

  1955cited by this paper

• The effect of meningococcal vaccines on new generation of systemic inflammatory markers in children

  2025cites this paper
• Comparison of Knowledge Levels and Attitudes of Family Medicine Assistants About Meningococcal Infection and Vaccines Before and After Education

  2025cites this paper
• Promising pharmaceutical development of vaccines for the prevention of meningococcal infection

  2023cites this paper
• Up-to-Date Review of Meningococcal Meningitis: Global Challenges and Recommendations

  2023cites this paper
• Meningococcal Vaccines of New Generations – the First 20 Years of Use

  2021cites this paper
• The Skin and Neurologic Disease

  2021cites this paper
• Challenges and Recommendations to Reducing Burden of Diphtheria in Refugee Camps

  2020cites this paper
• Meningococcal Carriage, Disease and Vaccination

  2020cites this paper
• Infection and Drug Resistance Dovepress

  2019cites this paper
• Safety of a quadrivalent meningococcal conjugate vaccine in healthy subjects aged 9 months to 55 years in Vietnam

  2019cites this paper
• Cutaneous Manifestations of Gram‐negative Infections

  2019cites this paper
• Clinical and economic estimation of children’s pharmacotherapy with meningococcial infections in Ukraine

  2019cites this paper
• Analysis of the impact of corticosteroids adjuvant treatment during experimental invasive meningococcal infection in mice

  2018cites this paper
• Invasive Meningococcal Disease in the Vaccine Era

  2018influential citation
• Transposon mutagenesis-based identification of meningococcal genes required for interactions with respiratory epithelial cells.

  2018cites this paper
• Seroprevalence study of infectious laryngotracheitis virus antibody of commercial layer in Gazipur Districts of Bangladesh

  2018cites this paper
• Costs of Invasive Meningococcal Disease: A Global Systematic Review

  2018cites this paper
• Deep coal mining and meningococcal meningitis in England and Wales, 1931–38: Ecological study, with implications for deep shaft mining activities worldwide

  2017cites this paper
• An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate

  2016cites this paper
• Control of invasive meningococcal disease: is it achievable?

  2016cites this paper
• Meningococcal Disease in China

  2016cites this paper
• Issues in pediatric vaccine-preventable diseases in low- to middle-income countries

  2016influential citation
• Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles

  2016cites this paper
• Современные менингококковые вакцины: сильные и слабые стороны, ближайшие перпективы

  2016cites this paper
• Vaccines and Autoimmunity: Meningococcal Vaccines

  2015cites this paper
• Identification and Therapeutic Potential of a Vitronectin Binding Region of Meningococcal Msf

  2015cites this paper
• Safety and immunogenocity of a novel combined Haemophilus influenzae type b–Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old

  2015cites this paper
• Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2–10 Years of Age

  2015cites this paper
• The Capsule Polymerase CslB of Neisseria meningitidis Serogroup L Catalyzes the Synthesis of a Complex Trimeric Repeating Unit Comprising Glycosidic and Phosphodiester Linkages*

  2015cites this paper
• The capsular group B meningococcal vaccine, 4CMenB: clinical experience and potential efficacy

  2015cites this paper
• Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

  2014cites this paper
• Review of meningococcal vaccines with updates on immunization in adults

  2014cites this paper
• Meningococcal disease in children and teenagers.

  2014cites this paper
• Prevention and treatment of meningococcal disease.

  2014cites this paper
• Epidemiology and Prevention of Bacterial Meningitis and Meningococcal Serogroup B Infection

  2014influential citation
• MenHibrix: a new combination meningococcal vaccine for infants and toddlers.

  2014cites this paper
• [Meningococcal disease in the Metropolitan Region of Chile and its correlation with environmental factors].

  2014cites this paper
• A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.

  2014cites this paper
• Hyperendémie d'infection invasive à méningocoque B : description de la série de cas de la souche B:14:P1-7,16 dans le Béarn et état des lieux à un an du plan de vaccination ciblée

  2014cites this paper
• Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.

  2013influential citation
• Long-Term Sequelae of Childhood Bacterial Meningitis

  2013cites this paper
• A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?

  2013cites this paper
• Vaccination against meningitis B: is it worth it?

  2013cites this paper
• Enfermedad meningocócica en España (1940-2012). Tendencias de la incidencia y evolución de los serogrupos antes y después de las campañas de vacunación

  2013cites this paper
• Infectious diseases and their prevention across the Seven Ages of Man Вакцинация в современном мире

  2012cites this paper
• VACCINATIONS IN ADULTS MENINGOCOCCAL AND TRAVELLERS ’ VACCINATIONS

  year unknowncites this paper